prof. MUDr. Rostislav Vyzula, CSc.
Professor, Comprehensive Cancer Care Department
Correspondence Address:
Žlutý kopec 534/7, 656 53 Brno
E‑mail: |
---|
Total number of publications: 404
2012
-
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
International Journal of Oncology, year: 2012, DOI
-
Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
CARDIOVASCULAR TOXICOLOGY, year: 2012, volume: 12, edition: 3, DOI
-
Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer
Cancer Biomarkers, year: 2012, volume: 12, edition: 4-5, DOI
-
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
Journal of Translational Medicine, year: 2012, volume: 10, edition: March, DOI
-
Cirkulující miRNA v séru pacientů s renálním karcinomem jako potenciální biomarkery.
Year: 2012, type: Conference abstract
-
Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells
International Journal of Colorectal Disease, year: 2012, volume: 27, edition: 11, DOI
-
Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population
European Journal of Medical Research, year: 2012, volume: 17, edition: Jun, DOI
-
Diseminovaný kolorektální karcinom. Strategie léčby.
Year: 2012, edition: Vyd. 1., number of pages: 76 s.
-
Epidemiologie, prevence a léčba kolorektálního karcinomu dle dostupných českých a mezinárodních dat
Year: 2012, edition: Vydání 1., number of pages: 199 s.
-
Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry
BMC Public Health, year: 2012, volume: 12, edition: "art. 117", DOI